Team:NUDT CHINA/Notebook

From 2014.igem.org

(Difference between revisions)
 
Line 28: Line 28:
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Modeling">Modeling</a> </li>
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Modeling">Modeling</a> </li>
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Notebook">Notebook</a> </li>
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Notebook">Notebook</a> </li>
-
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Safety">Safety</a> </li>
+
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Safety">Safety Policy & Practices</a> </li>
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Attributions">Attributions</a> </li>
<li><a href="https://2014.igem.org/Team:NUDT_CHINA/Attributions">Attributions</a> </li>
</ul>
</ul>

Latest revision as of 03:03, 18 October 2014


The Transformation of Our iGEM Ideas

Originally, we were attracted by the Shortest Path Problem, which aims to find the shortest path in a directed graph that can link the beginning node and ending node. Be inspired, we decided to design a cascade pathway in vivo which can help us read out the answer of Shortest Path Problem directly by the life stage of E. coli.

The main problem in the design are:

  • how to describe a route in E. coli;
  • how to build different routes in E. coli;
  • how to compare the length of different pathways.

To solve the first problem, we built devices that contains promoter, RBS, target gene (CDS) and terminator to simulate the nodes and lines in directed graph: the promoters are nodes and the target fragment are lines. When the promoter is activated, the target gene can coding protein which then activate the next promoter as regulatory element. This regulatory process can describe how a man the walking in a directed graph: he departed from the node P1, went through the line L and finally arrived at the spot P2. In this way, theoretically, we can describe any given directed graph in E. coli. (For further details about the coding of the graph, please refer to the project profile of our wiki) (Fig. 1)


Fig. 1 One promoter and one target gene can simulate one node and one line

After building one complete graph in E. coli, different route should be labelled and tested independently so that we can get the length indirectly by the time of whole travel from beginning to ending. Then we can selected the quickest one as the shortest route. However, we are stuck in the second problem: how to build different route.

First design:

In each regulatory unit, three different restrict enzyme sites are put between the promoter and RBS, target gene and terminator, terminator and next promoter, respectively. (Fig. 2)


Fig. 2 the position of three different restrict enzyme sites

In this way, we can cut the RBS and target gene out which means this route does not have line L (we link the 1, 2 (or 1, 3) to keep the circle structure of plasmid). Then we can test this route by the time of arriving at the ending node which reported by the report gene (we used the GFP).

Second stage:

But we found that it was not easy get so many different good restrict enzyme. So we change the design slightly. (Fig. 3)


Fig. 3 the position of two same restrict enzyme sites

In this way, we can still finish the function of first stage but save my restrict enzymes.

Third stage:

The last problem is how to compare the length of different pathway. Firstly, we decide to build all the possible route and test them. That is to say, we need to cut out 1, 2, 3,…,device(s) so that we can test the entire route, which is named exhaustion, quite time-consuming. Later, we found a better way where we can only cut one device which means we only need to build n graph if the graph has n lines.

Provided that we have 5 lines in a graph like Fig. 4.


Fig. 4 a graph of 5 lines, where node 1 is the beginning node 4 is the ending

According our method to find the shortest path, the first step is to build 6 different systems. Then we tested the “finished time” of each systems. Here is the systems and their “finish time”.

SystemArrayTime (Theoretically)
111112 units
011112 units
101112 units
110112 units
111013 units
11110unreachable

Noticed that without line L5, the ending is inaccessible which implicates the L5 is indispensable. Though it does not block the accessibility, the absence of L4 slows down the arrival, which implies that L4 is on the shortest path. Thus, from the date of the chart above, we can pick out the shortest path is:

Protocol

Here are the recapitulative protocols of the experiments that we have used.

Polymerase Chain Reaction (PCR)

Most of our PCRs was performed with the Recombinant Taq DNA Polymerase TaKaRa Taq(TM) or PrimeSTAR(R) HS DNA Polymerase and dNTP mixture (2.5mM each) under the standard 3-step PCR protocol. Touch-down RCR procedures were also used for several times to inhibit the nonspecific amplification. (Refer to the instruction for more details).

Plasmid Preparation

We used the TIANprep Mini Plasmid Kit (TIANGEN) to perform all of our plasmid preparation on bacteria with target plasmid. (Refer to the TIANGEN instruction for more details).

Gel Electrophoresis & Gel Extraction

After the gel electrophoresis (normal experiment), we used the TIANgel Midi Plasmid Kit (TIANGEN) to extract all our target fragment in gel. (Refer to the TIANGEN instruction for more details).

Endonuclease Digestion & Ligases

The enzymes we had used were EcoR I, Spe I, Xba I, Pst I, Cla I, Sal I, Kpn I (digestion), T4 DNA ligase (ligase) all of them were bought from TaKaRaTM. The digestion and ligase systems were built following the instructions of TaKaRa(TM).

Fluorescent Fusion Protein Gene Expression

Fluorometric measurement were processed with Fluoroskan(R) Ascent FL from ThermoTM using the filters of 485nm and 538nm. The E.coli to be tested was cultured in liquid LB media containing 35μg/mL chloramphenicol to OD0.6, than split into 96 well plates (from ThermoTM) by 150μL/well. The plate was then put into the Fluoroskan(R) Ascent FL and cultured in 25℃ and background shake of 90rpms. The Fluorometric measurement was processed with the interval time of 10 minutes.

Blue print

According our design of the whole cascade regulatory pathway as Fig. 1 showed, we can solve the Shortest Path Problem. However, building and standardizing these devices and systems means drawing the blue print.

SystemsFunctional fragments at plasmid
System “111”
System “011”
System “101”
System “110”

Fig. 1 regulatory pathways

Thus, we drew a picture of our experiment procedure. (Fig. 2)


Fig. 2 experiment procedure

Week Events

Following our big plan, we started our daily experiment.

TypeWeekOperationResult
Learn2013.12 - 2014.4Learing Molecular Cloning
Developing suitable protocols for Molecular Cloning
Build2014.4.19 - 5.1Amplifying and endonuclease digest plasmids of BBa_C0012, BBa_B0015, BBa_C0080, BBa_K082003 and BBa_C0062 (from Nanjing University)Getting plasmid of BBa_C0012, BBa_B0015, BBa_C0080 & BBa_K082003 but finding BBa_C0062 invalid
LearnDeveloping suitable protocols for the operation of PSB1C3 plasmid
Build2014.5.2 - 5.18Connecting BBa_C0012 & BBa_B0015, colony PCRTested positive
Build2014.5.24 - 6.7Adding [T7+RBS] to the [BBa_C0012+BBa_B0015] and sequencing itMutation sequenced
Build2014.6.20 - 6.21Adding [T7+RBS] to the [BBa_C0012+BBa_B0015] and sequencing itCorrect [T7+RBS + BBa_C0012+BBa_B0015]
Test2014.6.28 - 8.17Testing the function of [T7+RBS + BBa_C0012+BBa_B0015] by SDS-PAGEGetting weak stripe from SDS-PAGE (due to low expression with LVA tag)
BuildPicking out BBa_C0062 by PCR valid plasmidStandardized BBa_C0062
BuildStandardizing three restrict enzyme sites: Cla I, Sal I & Kpn I (basic parts)Standardized Cla I, Sal I & Kpn I and Getting correct them with name BBa_K1532000, BBa_K1532001, BBa_K1532002
BuildAdding K09100 to [T7+RBS+ BBa_C0012+BBa_B0015]Fluorescent expression curve of [T7+RBS+BBa_C0012+BBa_B0015+K09100]
BuildBuild device [BBa_R0010 + RBS + C0080 + BBa_B0015]Sequenced correct
LearnDeveloping protocol for technique of fluorescent fusion protein gene expression (in BL21(DE3))Fluorescent expression curve of [T7+RBS+BBa_C0012+BBa_B0015+K09100]. Valid bacteria with Lux I plasmid
Build2014.8.29 - 9.1Amplifying, transforming Lux I (from Wuhan University) and SDS-PAGE
OtherConfecting culture medium with AHL
Test2014.9.1 - 9.16Testing the interaction of IPTG and AHLUnusual phenomenon that needs further experiment and discussion
Build2014.9.17 - 9.22Synthesizing the devices of Syn_EGFP, Syn_LuxR, Syn_LuxRI and Syn_Arac and sub-cloning them into E.coli PSB1C3Getting correct Syn_EGFP, Syn_LuxR, Syn_LuxRI and Syn_Arac and respectively named BBa_K1532003~ BBa_K1532006
Build2014.9.23 - 9.26Building [PJ23104+LacI]Getting sequenced (but untested) [PJ23104+LacI] (named BBa_K1532007)
Other2014.9.27 - 9.28Sending BBa_K1532000~ BBa_K1532006Arriving at 2014.9.30
Build2014.9.23 - 10.7Building system of “111”, ”011”, ”101” and ”110”Finished at 2014.10.15
Other2014.10.4Sending BBa_K1532007
Test2014.10.13Testing the function of [PJ23104+LacI]Unfinished

Click here to edit this page! Click here to upload!